BBHC
LKFT

Brown Brothers Harriman & Co’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Brown Brothers Harriman & Co’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-26
Closed -$3K – 1156
2020
Q4 		$3K Buy
+26
New +$3.18K ﹤0.01% 991

Other funds holding LKFT

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Brown Brothers Harriman & Co's LKFT Position: Q1 2021 in Review

Brown Brothers Harriman & Co sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2021, closing a stake of 26 shares — an estimated $3K sold.

Brown Brothers Harriman & Co first reported a position in LKFT in Q4 2020 and held it in 1 quarter. The position peaked at $3K in Q4 2020. 132 funds tracked by Wall St. Rank hold LKFT as of Q1 2021.

  • Brown Brothers Harriman & Co reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 26 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2021, an estimated $3K.
  • Brown Brothers Harriman & Co first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2020 and held it in 1 quarter.
  • Brown Brothers Harriman & Co's Lakefront Biotherapeutics American Depositary Shares position peaked at $3K in Q4 2020.
  • 132 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2021.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2021, filed 13 May 2021.